A woman in her early 30s had conceived through in vitro fertilization (IVF). Her rising hormone levels confirmed it. But the ...
A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled "Massive calcified solid ...
Additional funding provides financial flexibility to expand opportunistic share repurchases and support strategic and operational initiativesNEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- TG ...
In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...
Your time is up, you little shit, I thought. I was going to kill this thing.
This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...
Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...
The White House says a red spot on President Donald Trump’s neck comes from a prescribed skin cream. Photographers captured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results